newsfilter
← Interviews
a16z7 min

Pande & Conde on: Players and Paths for Healthcare Startups

Pande, Conde, Vijay Pandey

Fireside Chat, Interview

The discussion outlines a strategic framework for healthcare startups, contrasting the lengthy regulatory paths of therapies and diagnostics with the rapid market entry offered by Laboratory-Developed Tests and R&D tool sales. Highlighting the $75 billion U.S. R&D market, the analysis features success stories like Atomab and Illumina to demonstrate how founders can leverage non-exclusive licensing models instead of pursuing costly end-user commercialization. Ultimately, the presentation advises entrepreneurs to align their go-to-market approach with specific proof points and regulatory requirements, choosing between partnership-based platforms and integrated drug development based on their technology's unique capabilities.